miR‐126‐3p Serves as a Biomarker for Hepatitis B Virus‐Associated Chronic Acute Liver Failure and Regulates Inflammation by Regulating ERRFI1
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Yiping Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: MicroRNAs, Inflammation, Adaptor Proteins, Signal Transducing, Hepatitis B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Study on the effect of early tracheal extubation combined with "Six Character Technique" gong method on acute lung injury after liver transplantation and its m….
Abstract (Originalsprache)
Hepatitis B virus‐associated chronic acute liver failure (HBV‐ACLF) is the leading cause of ACLF, affecting approximately 90% of patients with ACLF. The objective of this study was to investigate the clinical relevance of miR‐126‐3p on HBV‐ACLF as well as the regulatory impact of ERRFI1 and miR‐126‐3p on the inflammatory response caused by ACLF via in vitro experimental methodologies. RT‐qPCR was utilized to quantify the expression levels of miR‐126‐3p, ERRFI1, NLRP3, caspase 1, and IL‐1β. The clinical function of miR‐126‐3p was assessed using ROC analysis or Kaplan‐Meier curve. Cell proliferation was quantified via the CCK‐8 assay, while the dual‐luciferase reporter assay was employed to confirm the specific binding interaction between miR‐126‐3p and ERRFI1. In patients with HBV‐ACLF, a significant downregulation of miR‐126‐3p expression was observed; The level of miR‐126‐3p served as a prognostic indicator for the progression of HBV‐ACLF, with reduced expression being associated with an unfavorable clinical outcome. In addition, miR‐126‐3p was found to modulate LPS‐induced cell proliferation, and inflammation in THLE‐2 cells through the regulation of ERRFI1 expression. Therefore, miR‐126‐3p might serve as a biomarker for HBV‐ACLF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, China.
Förderung
- Study on the effect of early tracheal extubation combined with "Six Character Technique" gong method on acute lung injury after liver transplantation and its m…
Zitieren
APA
Luo, Y., Ren, Q., He, J., & Wu, M. (2025). miR‐126‐3p Serves as a Biomarker for Hepatitis B Virus‐Associated Chronic Acute Liver Failure and Regulates Inflammation by Regulating ERRFI1. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70252
Vancouver
Luo Y, Ren Q, He J, Wu M. miR‐126‐3p Serves as a Biomarker for Hepatitis B Virus‐Associated Chronic Acute Liver Failure and Regulates Inflammation by Regulating ERRFI1. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70252
BibTeX
@article{Luo2025,
author = {Luo, Yiping and Ren, Qiuping and He, Jun and Wu, Menghang},
title = {miR‐126‐3p Serves as a Biomarker for Hepatitis B Virus‐Associated Chronic Acute Liver Failure and Regulates Inflammation by Regulating ERRFI1},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70252}
}
EUVIMED